UNSPSC 51385803: Lornoxicam

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H10ClN3O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ER09126G7A, chemically known as 6-chloro-4-hydroxy-2-methyl-n-2-pyridyl-2h-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide but generally known as lornoxicam, which bears US NIH Compound Identifier 5282204. European Medicines Agency schedules Lornoxicam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08589MIG.

UNSPSC 51385803 Lornoxicam is a Commodity code that captures pharmaceutical products state and local governments procure for emergency response, public health, and harm-reduction initiatives. The recent solicitation activity under this code shows state and local agencies purchasing naloxone (an opioid antagonist used in overdose response) and drug deactivation systems rather than lornoxicam specifically—a disconnect between the code's nominal scope and what agencies are actually buying. The work involves procuring finished pharmaceuticals and related medical systems in bulk quantities, with vendors responsible for delivery, storage compliance, and continuity of supply to public health facilities and emergency-response programs.

Seminole County, Florida represents the identifiable recent activity under this code. The county issued an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option, includes a three-month probationary period, and requires vendors to meet federal compliance standards (E-Verify, drug-free workplace, insurance coverage including workers' compensation and general liability), with potential FEMA funding implications. Beyond this single opportunity, the code shows sparse recent state and local procurement activity; no other jurisdictions or issuing bodies appear in the available opportunities block, limiting visibility into broader geographic or issuer-type patterns.